Go Deep
Caplin Point Laboratories Limited
Caplin Point Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 21,931 | 32.7 | 6.05 | 0.00 | 2,854.00 |
| Sep 2026 | 21,931 | 32.7 | 6.05 | 0.00 | 2,854.00 |
| Sep 2026 | 21,931 | 32.7 | 6.05 | 0.00 | 2,854.00 |
| Oct 2026 | 22,426 | 30.1 | 5.58 | 0.00 | 2,631.90 |
| Oct 2026 | 22,070 | 28.2 | 5.21 | 0.00 | 2,460.80 |
Caplin Point Laboratories Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 6,103,600,000.0 | 6,001,600,000.0 | 5,427,700,000.0 | 5,102,200,000.0 |
| Net Profit | 1,769,100,000.0 | 1,701,100,000.0 | 1,638,800,000.0 | 1,528,000,000.0 |
| EPS | 23.3 | 22.4 | 21.6 | 20.1 |
Caplin Point Laboratories Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 21,713,800,000.0 | 19,212,300,000.0 | 16,795,500,000.0 | 14,538,200,000.0 | — |
| Net Profit | 6,412,400,000.0 | 5,363,100,000.0 | 4,570,800,000.0 | 3,762,600,000.0 | — |
| EPS | 84.4 | 70.6 | 60.2 | 49.6 | — |
Caplin Point Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 40,454,800,000.0 | 32,108,600,000.0 | 26,981,200,000.0 | 21,914,000,000.0 | — |
| Total Liabilities | 4,146,800,000.0 | 3,244,700,000.0 | 3,512,900,000.0 | 2,841,300,000.0 | — |
| Total Equity | 35,864,200,000.0 | 28,504,900,000.0 | 23,157,100,000.0 | 18,804,800,000.0 | — |
Owes vs Owns
Caplin Point Laboratories Limited owed ₹0.10 for every ₹1 it owned in Mar 2026, down from ₹0.13 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.10× | 0.10× | 0.13× | 0.13× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Caplin Point Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 24.5%Receivables 20.4%Inventory 10.6%Fixed assets (tangible) 18.8%Intangible assets 1.3%Other assets 24.3%
How it's funded — Mar 2026
Payables 7.3%Other liabilities 2.9%Shareholders' equity 89.7%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 991.8 | 960.1 | 783.8 | 694.6 |
| Receivables | 825.8 | 632.5 | 542.7 | 394.1 |
| Inventory | 428.9 | 336.1 | 363.0 | 288.2 |
| Fixed assets (tangible) | 759.8 | 673.7 | 556.8 | 489.4 |
| Intangible assets | 53.8 | 15.6 | 12.5 | 11.2 |
| Long-term investments | 1.8 | 1.7 | 1.7 | 1.5 |
| Other assets | 983.7 | 591.1 | 437.6 | 312.5 |
| Liabilities & equity | ||||
| Short-term debt | 0.6 | 0.6 | 0.3 | 3.4 |
| Long-term debt | 2.1 | 2.9 | 0.9 | 0.9 |
| Payables | 296.0 | 217.6 | 229.6 | 152.6 |
| Other liabilities | 116.0 | 103.4 | 120.5 | 127.2 |
| Shareholders' equity | 3,630.8 | 2,886.4 | 2,346.8 | 1,907.3 |
| Net tangible assets | 3,532.6 | 2,834.9 | 2,303.2 | 1,869.3 |
Caplin Point Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 5,232,400,000.0 | 4,323,700,000.0 | 3,183,900,000.0 | 2,713,700,000.0 | — |
| Investing Activities | -5,823,000,000.0 | -3,347,300,000.0 | -3,200,400,000.0 | -2,175,800,000.0 | — |
| Financing Activities | -464,600,000.0 | -383,200,000.0 | -380,700,000.0 | -281,700,000.0 | — |